web analytics
6.9 C
Karachi
Wednesday, January 8, 2025
HomeTagsMerck

All Stories: Merck

Winrevair: Merck wins UK approval for lung disease drug

UK's Medicines and Healthcare products Regulatory Agency said on Tuesday it had approved Merck's Winrevair to treat a rare lung condition, marking another win...

Merck’s colorectal cancer therapy fails late-stage trial

Merck said on Wednesday a combination of its experimental drug and blockbuster therapy Keytruda failed a late-stage trial testing it in previously treated patients...

Merck raises 2024 profit forecast on cancer drug sales

Merck & Co on Thursday raised its annual profit and revenue forecasts on the back of strong sales for its blockbuster cancer drug Keytruda,...

Merck says multiple sclerosis drug has blockbuster potential

The CEO of Germany's Merck KGaA said the company's experimental multiple sclerosis drug can be a "blockbuster", an industry term for annual sales that...

Prevymis: Merck’s viral infection drug gets EU recommendation

Merck & Co said on Tuesday the European Union medicines regulator recommended a marketing authorisation for the company's drug Prevymis to treat a type...

Molnupiravir: China grants conditional approval for COVID treatment

China has granted conditional approval for the import of Merck's COVID-19 treatment Molnupiravir, China's medical products regulator said on Friday. Molnupiravir, developed by Merck which...

WHO recommends Merck’s COVID pill for high-risk patients

A World Health Organization (WHO) panel on Wednesday backed the use of molnupiravir- Merck & Co's COVID-19 antiviral pill- for high-risk patients. The expert panel...

UK to begin testing Merck’s COVID pill for hospitalised patients

UK scientists will begin testing Merck and Ridgeback Biotherapeutics' antiviral pill molnupiravir as a possible treatment for patients hospitalised with COVID-19, amid the worldwide...

Cheap version of Merck COVID pill to be made for poorer nations

A UN-backed agency has struck a deal for nearly 30 generic drugmakers to make low-cost versions of Merck's COVID-19 pill molnupiravir for poorer nations,...

Drugmaker to launch generic COVID-19 Merck drug at about Rs70

Indian drugmaker Dr Reddy's Laboratories Ltd will launch its generic version of Merck's antiviral COVID-19 pill, molnupiravir, and price it at 35 rupees (Rs70...

Belgium to buy 10,000 courses each of Pfizer and Merck COVID-19 pills

Belgium will buy 10,000 courses each of the COVID-19 pills developed by Pfizer and Merck, a spokesman for the health ministry said in an...

Japan health panel approves Merck’s oral COVID-19 treatment

A Japanese health ministry panel on Friday recommended approval of the COVID-19 antiviral pill developed by Merck, part of Prime Minister Fumio Kishida's plan...

US regulator authorizes Merck’s Covid pill

The US Food and Drug Administration (FDA) on Thursday authorized Merck's Covid pill for high risk adults, a day after giving the green light...

France cancels order for Merck’s COVID-19 antiviral drug

France has cancelled its order for Merck's COVID-19 antiviral drug following disappointing trial data and hopes instead to receive Pfizer's competing drug before the...

Merck Covid pill backed for EU emergency use

The EU's drug watchdog on Friday backed Merck's anti-Covid pill for emergency use ahead of its formal authorisation and started reviewing Pfizer's antiviral treatment...

Indonesia reviewing Merck COVID-19 pill, up to 1 mln doses targeted

Indonesia is reviewing a COVID-19 experimental antiviral pill- molnupiravir- produced by Merck for domestic use, its food and drug agency (BPOM) chief said on...

How does Merck’s COVID-19 pill compare to Pfizer’s?

Pfizer and Merck have developed experimental antiviral pills that have shown promising efficacy in trials of adults with COVID-19 who are at high risk...

Britain approves Merck’s COVID-19 pill in world first

Britain on Thursday became the first country in the world to approve a potentially game-changing COVID-19 antiviral pill -molnupiravir- jointly developed by Merck and...

Molnupiravir: Countries rush to buy Merck experimental COVID-19 pill

Merck has signed eight deals to sell more than a total of 2 million courses of its experimental COVID-19 pill molnupiravir to governments around...

Merck signs pact to allow more companies to manufacture COVID-19 pill

Merck has signed a licensing agreement with the United Nations-backed Medicines Patent Pool (MPP) that will allow more companies to manufacture generic versions of...
-Advertisement-
 

Trending

BREAKING NEWS

MUST READ